Alum triggers infiltration of human neutrophils ex vivo and causes lysosomal destabilization and mitochondrial membrane potential‐dependent NET‐formation. Issue 10 (29th August 2020)

• Record Type: Journal Article
• Authors: Reithofer, Manuel; Karacs, Jasmine; Strobl, Johanna; Kitzmüller, Claudia; Polak, Dominika; Seif, Katharina; Kamalov, Meder; Becker, Christian F. W.; Greiner, Georg; Schmetterer, Klaus; Stary, Georg; Bohle, Barbara; Jahn‐Schmid, Beatrice
• Is Part Of: FASEB journal. Volume 34:Issue 10(2020)
• Page Start: 14024
• Page End: 14041
• Publication Date: 2020-08-29
• Subjects: aluminium hydroxide -- vaccine -- adjuvant -- innate response -- neutrophils -- NET; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202001413R
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Aluminium salts have been used in vaccines for decades. However, the mechanisms underlying their adjuvant effect are still unclear. Neutrophils, the first immune cells at the injection site, can release cellular DNA together with granular material, so‐called neutrophil extracellular traps (NETs). In mice, NETs apparently play a role in aluminium hydroxide (alum)‐adjuvant immune response to vaccines. Although no experimental data exist, this effect is assumed to be operative also in humans. As a first step to verify this knowledge in humans, we demonstrate that the injection of alum particles into human skin biopsies ex vivo leads to similar tissue infiltration of neutrophils and NET‐formation. Moreover, we characterized the mechanism leading to alum‐induced NET‐release in human neutrophils as rapid, NADPH oxidase‐independent process involving charge, phagocytosis, phagolysosomal rupture, Ca 2+ ‐flux, hyperpolarization of the mitochondrial membrane, and mitochondrial ROS. Extracellular flow and inhibition experiments suggested that no additional energy from oxidative phosphorylation or glycolysis is required for NET‐release. This study suggests a so far unappreciated role for neutrophils in the initial phase of immune responses to alum‐containing vaccines in humans and provides novel insights into bioenergetic requirements of NET‐formation.